This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is false about multiplace hyperbaric oxygenation chambers? a. The chamber ... (Read 99 times)

DyllonKazuo

  • Hero Member
  • *****
  • Posts: 565
Which of the following is false about multiplace hyperbaric oxygenation chambers?
 
  a. The chamber normally is filled with 100 O2.
  b. Air locks allow entry and egress of care-givers.
  c. Pressures of 6 ATA or more can be ap-plied.
  d. Care is provided directly within the chamber.

Question 2

In which of the following procedures is air embolism a potential complication? 1. Central line placement 2. Lung biopsy 3. Hemodialysis
 
  a. 1 and 2 only
  b. 2 and 3 only
  c. 1 and 3 only
  d. 1, 2, and 3



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

komodo7

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

ANS: A
The multiplace chamber is filled with air.

Answer to Question 2

ANS: D
Air embolism is a complication that can occur with certain cardiovascular procedures, lung biop-sy, hemodialysis, and central line placement.





 

Did you know?

The liver is the only organ that has the ability to regenerate itself after certain types of damage. As much as 25% of the liver can be removed, and it will still regenerate back to its original shape and size. However, the liver cannot regenerate after severe damage caused by alcohol.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library